As regenerative medicine gains increasing attention, many patients wonder whether biologic injections can eliminate the need for surgery altogether. While these treatments can play an important role in orthopedic care, they are not a universal substitute for surgical treatment. Understanding when biologic injections help and when surgery is still necessary can help patients make more informed decisions about their care.
How Biologic Injections Work to Support Joint and Tissue Healing
Biologic injections are regenerative treatments designed to support the body’s natural healing processes. Instead of simply masking pain, these therapies aim to reduce inflammation and stimulate tissue repair within joints, tendons, and ligaments. They are increasingly used in orthopedic and sports medicine to address chronic injuries and early joint degeneration.
One of the most widely used options is Platelet-Rich Plasma (PRP). PRP is created by concentrating platelets from a patient’s own blood. These platelets contain growth factors that can stimulate healing and help repair damaged tissue. Another category includes cell-based therapies, which use regenerative cells derived from the patient’s body to promote tissue regeneration and support recovery in injured or degenerating areas.
Bone marrow aspirate concentrate (BMAC) is another biologic treatment used in regenerative orthopedics. This therapy involves collecting a small amount of bone marrow, typically from the pelvis, and concentrating the regenerative cells and growth factors it contains. These components may help support tissue repair, reduce inflammation, and promote healing in joints and soft tissues affected by injury or degeneration.
When Regenerative Treatments May Be Recommended
Biologic injections are often most effective in the early or moderate stages of orthopedic conditions. When joint structures still have viable tissue capable of healing, these therapies may reduce inflammation and support the repair process. Patients with mild to moderate osteoarthritis, chronic tendon injuries, or ligament strain may experience significant improvement in pain and function.
For active individuals, regenerative medicine may also provide an appealing option because it is minimally invasive and typically requires little downtime. In some cases, these treatments allow patients to continue participating in work, sports, or other physical activities while managing symptoms and slowing the progression of joint degeneration.
However, results can vary depending on the severity of the injury and the overall health of the surrounding tissue. While biologic injections can support healing, they cannot reconstruct damaged structures that require mechanical repair.
Why Biologic Injections Cannot Replace Surgery in Some Cases
Certain orthopedic conditions involve structural damage that regenerative therapies cannot correct. Large tendon tears, severe ligament ruptures, and advanced joint degeneration often require surgical intervention to restore stability and proper joint mechanics. For example, a complete ACL tear or a significantly torn hip labrum typically needs surgical repair to regain strength and function at desirable levels.
Similarly, advanced arthritis that causes major cartilage loss or joint deformity may eventually require joint replacement. In these situations, biologic injections may reduce inflammation temporarily, but they cannot rebuild severely damaged joint surfaces or restore alignment within the joint.
Because of these limitations, biologic treatments are best viewed as one tool within a broader orthopedic treatment strategy rather than a complete replacement for surgery.
Biologic Injections as a Bridge to Surgery
Even when surgery may ultimately be necessary, biologic injections can still provide meaningful benefits. Many orthopedic specialists use regenerative therapies as a bridge treatment that helps patients manage symptoms and maintain activity levels while delaying surgery.
This approach may be particularly helpful for younger patients with early arthritis who want to postpone joint replacement, athletes who wish to complete a season before considering surgery, or individuals who need time to prepare for a surgical procedure. By reducing inflammation and improving joint function, regenerative injections can extend the period during which a patient can remain active without undergoing a major operation.
The Importance of an Individualized Treatment Plan
The decision between regenerative treatments and surgery depends on multiple factors, including the type of injury, the degree of tissue damage, imaging findings, and the patient’s activity goals. At the American Hip Institute, our experienced orthopedic specialists evaluate all of these factors to determine the most appropriate treatment approach.
Frequently Asked Questions about Biologic Injections
- Can PRP injections replace orthopedic surgery?
PRP injections may help reduce pain and improve healing in some conditions, but they cannot repair major structural damage such as large tendon tears, severe arthritis, or complete ligament ruptures that often require surgery.
- What conditions are commonly treated with regenerative injections?
Biologic injections are often used for mild to moderate osteoarthritis, tendon injuries, ligament strains, and chronic joint inflammation, particularly when patients want to explore non-surgical treatment options.
- Can biologic injections delay joint replacement surgery?
In some cases, regenerative treatments like PRP or viscosupplementation can help manage symptoms and improve joint function, allowing patients to delay joint replacement surgery while maintaining an active lifestyle.
Reference Links:
AUTHOR: Benjamin D. Kuhns, MD, MS – Orthopedic Hip Surgeon & Research Director
Benjamin D. Kuhns, MD, MS is a board-certified orthopedic surgeon and Director of Research at the American Hip Institute in Des Plaines and Chicago, Illinois. He specializes in comprehensive hip care, including hip preservation, arthroscopy, open osteotomies, and primary and revision anterior approach hip arthroplasty. Dr. Kuhns also incorporates regenerative medicine techniques into personalized treatment strategies designed to restore function and accelerate return to activity.
Credentials & Recognition
Dr. Kuhns completed his Bachelor of Arts at Colgate University with a major in chemistry and a minor in history, followed by a Master of Science in Neuroscience from Northwestern University. He earned his medical degree from Case Western Reserve University School of Medicine, graduating with distinction in research and being inducted into the Alpha Omega Alpha honor society. He then completed orthopedic residency training at the University of Rochester Medical Center, where he received the Kenneth DeHaven Research Award for work linking femoroacetabular impingement to hip osteoarthritis. Following residency, Dr. Kuhns pursued fellowship training in adult hip preservation and reconstruction at The Steadman Clinic and completed advanced hip preservation training at the American Hip Institute. He has authored more than 40 peer-reviewed articles and book chapters on hip dysfunction and surgical management.
Clinical Expertise
Dr. Kuhns’ clinical focus includes non-operative management of hip pain through targeted physical therapy and injections, complex primary and revision hip arthroscopy, open hip preservation including periacetabular and femoral osteotomies, and robotic anterior approach total hip arthroplasty. In his role as a surgeon and researcher, he collaborates closely with patients to craft customized treatment plans aimed at optimizing functional outcomes and helping individuals return to the activities they enjoy, regardless of age. He is an active member of professional organizations, including the American Academy of Orthopaedic Surgeons and The Hip Preservation Society (ISHA).
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Kuhns or another qualified orthopedic specialist at the American Hip Institute.
Content authored by Dr. Kuhns and verified against official sources.
AUTHOR: Mark F. Schinsky, MD, FAAOS, CIME – Orthopedic Hip & Knee Replacement Surgeon
Mark F. Schinsky, M.D., FAAOS, CIME is a fellowship-trained, board-certified orthopedic surgeon specializing in adult reconstructive orthopaedic surgery, hip replacement, knee replacement, and regenerative medicine. He serves as Director of Complex Hip & Knee Replacement and is recognized for advanced expertise in minimally invasive, complex primary, and revision total joint replacement procedures.
Credentials & Recognition
Dr. Schinsky earned his medical degree from the Columbia University College of Physicians & Surgeons and completed elite orthopaedic training at Barnes-Jewish Hospital affiliated with Washington University in St. Louis, as well as RUSH University.
With extensive clinical experience and thousands of successful hip and knee replacements performed, Dr. Schinsky is widely respected for his precision, surgical judgment, and commitment to improving patient mobility and quality of life. He has also contributed to the design of innovative orthopaedic implants and regularly travels nationally and internationally to educate surgeons on the latest joint replacement technologies and surgical techniques.
Clinical Expertise
Dr. Schinsky focuses on minimally invasive joint replacement, complex primary and revision hip and knee arthroplasty, and advanced reconstructive procedures tailored to each patient’s anatomy and functional goals. He treats patients from the Chicagoland region and across the country who seek specialized expertise in complex joint reconstruction. His patient-centered approach emphasizes individualized care, modern surgical technology, and comprehensive recovery planning to restore long-term function and independence.
Medical Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Schinsky or another qualified orthopedic specialist at the American Hip Institute.
Content authored by Dr. Schinsky and verified against official sources.